ArticleAdvanced healthcare materials2026
Natural-Based Nanocomposite Ink Engineering for Seamless Multi-Material Integration in Extrusion-Based 3D Printing.
Article in Advanced healthcare materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Natural-Based Nanocomposite Ink Engineering for Seamless Multi-Material Integration in Extrusion-Based 3D Printing.Advanced healthcare materials · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Multi-tissue regeneration remains a critical clinical challenge due to the lack of solutions that can replicate the hierarchical heterogeneity of such complex interfaces. While biofabrication approaches, such as extrusion-based, allow replicating robust, biomimetic, and layered designs, constructs are usually hindered by inadequate phase/layer integration, poor filler dispersion, and mismatched rheological and mechanical performances. This study introduces an ink engineering strategy as a solution for integrating natural-based nanocomposites in multi-tissue regenerative approaches. For that, two photocrosslinkable natural matrices: a protein-bovine serum albumin methacrylate (BSAMA), and a polysaccharide-hyaluronic acid methacrylate (HAMA)-are selected for their complementary mechanical and cytocompatibility profiles. Bioactive glass nanoparticles, known for osteoconductive potential, are functionalized and covalently immobilized within both matrices through EDC/NHS chemical coupling. This primary crosslinking enables uniform distribution of inorganic phases, unlocking tuneable rheological properties, adequate for extrusion 3D printing. Then, a secondary crosslinking, leveraging the photo-responsive moieties for post-printing photocuring, enables the obtention of seamlessly integrated robust multi-material constructs. Overall, BSAMA-based inks offer higher cytocompatibility, while HAMA-based inks provide superior mechanical strength. Their combination in multi-material constructs supports hASCs' metabolic activity and proliferation, confirming bioactivity and cytocompatibility; and finite element modeling validates their mechanical performance, supporting clinical potential for multi-tissue regeneration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.